120 related articles for article (PubMed ID: 35962692)
1. ASSESSMENT OF THE STATE OF IMMUNE SYSTEM IN PATIENTS WITH METASTATIC AND GLIAL BRAIN TUMORS AT THE PREPARATORY STAGE OF RADIOTHERAPY.
Gryazov AA; Lysianyi MI; Gryazov AB; Medvedovska YV
Wiad Lek; 2022; 75(7):1747-1751. PubMed ID: 35962692
[TBL] [Abstract][Full Text] [Related]
2. Outcomes and cost-effectiveness of gamma knife radiosurgery and whole brain radiotherapy for multiple metastatic brain tumors.
Lee WY; Cho DY; Lee HC; Chuang HC; Chen CC; Liu JL; Yang SN; Liang JA; Ho LH
J Clin Neurosci; 2009 May; 16(5):630-4. PubMed ID: 19269828
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors.
Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H
J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933
[TBL] [Abstract][Full Text] [Related]
4. Impact of allogenic and autologous transfusion on immune function in patients with tumors.
Guo JR; Xu F; Jin XJ; Shen HC; Liu Y; Zhang YW; Shao Y
Asian Pac J Cancer Prev; 2014; 15(1):467-74. PubMed ID: 24528076
[TBL] [Abstract][Full Text] [Related]
5. The Use of Treatment Response Assessment Maps in Discriminating Between Radiation Effect and Persistent Tumoral Lesion in Metastatic Brain Tumors Treated with Gamma Knife Radiosurgery.
Peker S; Samanci Y; Aygun MS; Yavuz F; Erden ME; Nokay AE; Atasoy Aİ; Bolukbasi Y
World Neurosurg; 2021 Feb; 146():e1134-e1146. PubMed ID: 33253956
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic radiosurgery for glial neoplasms of childhood.
Grabb PA; Lunsford LD; Albright AL; Kondziolka D; Flickinger JC
Neurosurgery; 1996 Apr; 38(4):696-701; discussion 701-2. PubMed ID: 8692387
[TBL] [Abstract][Full Text] [Related]
7. [A dynamic observation on serum cytokine and immunoglobulin (IgG, IgA, IgM) in patients with esophageal cancer].
Tang RG; Yuan XH; Tang TT; Tang XQ; Hang YQ; Qin HJ; Chen HM; Fang WZ; Long XK
Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jun; 41 Suppl():35-8. PubMed ID: 17767855
[TBL] [Abstract][Full Text] [Related]
8. Gamma Knife Radiosurgery for Metastatic Brain Tumors from Malignant Melanomas: A Japanese Multi-Institutional Cooperative and Retrospective Cohort Study (JLGK1501).
Matsunaga S; Shuto T; Yamamoto M; Yomo S; Kondoh T; Kobayashi T; Sato M; Okamoto H; Serizawa T; Nagano O; Kenai H; Obara T; Iwai Y; Yasuda S; Hasegawa T; Kubo K; Shidoh S; Mori K; Hayashi M; Inoue A; Onoue S; Gondo M
Stereotact Funct Neurosurg; 2018; 96(3):162-171. PubMed ID: 29969770
[TBL] [Abstract][Full Text] [Related]
9. Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases?
Chang WS; Kim HY; Chang JW; Park YG; Chang JH
J Neurosurg; 2010 Dec; 113 Suppl():73-8. PubMed ID: 21121789
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of [¹¹C]methionine PET for stereotactic radiation therapy with intensity modulated radiation therapy to metastatic brain tumors.
Miwa K; Matsuo M; Shinoda J; Aki T; Yonezawa S; Ito T; Asano Y; Yamada M; Yokoyama K; Yamada J; Yano H; Iwama T
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1139-44. PubMed ID: 22520479
[TBL] [Abstract][Full Text] [Related]
11. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
12. Evidence of a local immune activation in cystic brain tumors.
Boethius J; Lefvert AK; Sidén A
J Neurosurg; 1990 Dec; 73(6):933-5. PubMed ID: 2230976
[TBL] [Abstract][Full Text] [Related]
13. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
14. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Surgery in the Management of Adults With Metastatic Brain Tumors.
Nahed BV; Alvarez-Breckenridge C; Brastianos PK; Shih H; Sloan A; Ammirati M; Kuo JS; Ryken TC; Kalkanis SN; Olson JJ
Neurosurgery; 2019 Mar; 84(3):E152-E155. PubMed ID: 30629227
[TBL] [Abstract][Full Text] [Related]
15. CyberKnife stereotactic radiosurgery for intracranial neoplasms, with a focus on malignant tumors.
Bucholz RD; Laycock KA; Cuff LE
Technol Cancer Res Treat; 2010 Dec; 9(6):541-50. PubMed ID: 21070076
[TBL] [Abstract][Full Text] [Related]
16. Magnetic Resonance-Guided Laser-Induced Thermal Therapy for the Treatment of Progressive Enhancing Inflammatory Reactions Following Stereotactic Radiosurgery, or PEIRs, for Metastatic Brain Disease.
Hernandez RN; Carminucci A; Patel P; Hargreaves EL; Danish SF
Neurosurgery; 2019 Jul; 85(1):84-90. PubMed ID: 29860422
[TBL] [Abstract][Full Text] [Related]
17. A volumetric study of CyberKnife hypofractionated stereotactic radiotherapy as salvage for progressive malignant brain tumors: initial experience.
Giller CA; Berger BD; Fink K; Bastian E
Neurol Res; 2007 Sep; 29(6):563-8. PubMed ID: 17535568
[TBL] [Abstract][Full Text] [Related]
18. Radiosurgery in the management of brain metastasis: a retrospective single-center study comparing Gamma Knife and LINAC treatment.
Tuleasca C; Negretti L; Faouzi M; Magaddino V; Gevaert T; von Elm E; Levivier M
J Neurosurg; 2018 Feb; 128(2):352-361. PubMed ID: 28338441
[TBL] [Abstract][Full Text] [Related]
19. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors.
Gaspar LE; Prabhu RS; Hdeib A; McCracken DJ; Lasker GF; McDermott MW; Kalkanis SN; Olson JJ
Neurosurgery; 2019 Mar; 84(3):E159-E162. PubMed ID: 30629211
[TBL] [Abstract][Full Text] [Related]
20. A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02).
Drzymala RE; Wasserman TH; Won M; Shaw E; Cmelak AJ; Loeffler J; Souhami L;
Radiother Oncol; 2008 Apr; 87(1):89-92. PubMed ID: 18342381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
